ETR:SAE

Shop Apotheke Europe Competitors

€191.90

-5.60 (-2.84 %)

(As of 04/19/2021 12:00 AM ET)

Add

Compare

Today's Range

€190.20

Now: €191.90▼

€203.20

50-Day Range

€169.60

MA: €187.63▼

€202.50

52-Week Range

€64.70

Now: €191.90▼

€249.00

Volume72,023 shs

Average VolumeN/A

Market Capitalization$3.44 billion

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Shop Apotheke Europe (ETR:SAE) Vs. SZU, KWS, ZO1, HBH, B4B3, and ABI

Should you be buying SAE stock or one of its competitors? Companies in the sector of "consumer defensive" are considered alternatives and competitors to Shop Apotheke Europe, including Südzucker (SZU), KWS SAAT SE & Co. KGaA (KWS), zooplus (ZO1), HORNBACH Holding AG & Co. KGaA (HBH), Metro (B4B3), and Anheuser-Busch InBev SA/NV (ABI).

Shop Apotheke Europe vs. Südzucker Stock

Shop Apotheke Europe (ETR:SAE) and Südzucker (ETR:SZU) are both mid-cap consumer defensive companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.

Profitability

This table compares Shop Apotheke Europe and Südzucker's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shop Apotheke Europe	N/A	N/A	N/A
Südzucker	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings for Shop Apotheke Europe and Südzucker, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shop Apotheke Europe	1	4	7	0	2.50
Südzucker	0	4	2	0	2.33

Shop Apotheke Europe presently has a consensus target price of €199.75, indicating a potential upside of 4.09%. Südzucker has a consensus target price of €14.22, indicating a potential upside of 5.10%. Given Südzucker's higher probable upside, analysts clearly believe Südzucker is more favorable than Shop Apotheke Europe.

Valuation & Earnings

This table compares Shop Apotheke Europe and Südzucker's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shop Apotheke Europe	$968.06 million	3.56	$-20,918,040.00	(€1.17)	-164.58
Südzucker	$6.73 billion	0.41	$-149,474,400.00	(€0.73)	-18.48

Shop Apotheke Europe has higher earnings, but lower revenue than Südzucker. Shop Apotheke Europe is trading at a lower price-to-earnings ratio than Südzucker, indicating that it is currently the more affordable of the two stocks.

Shop Apotheke Europe vs. KWS SAAT SE & Co. KGaA Stock

Shop Apotheke Europe (ETR:SAE) and KWS SAAT SE & Co. KGaA (ETR:KWS) are both mid-cap consumer defensive companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability.

Earnings and Valuation

This table compares Shop Apotheke Europe and KWS SAAT SE & Co. KGaA's gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shop Apotheke Europe	$968.06 million	3.56	$-20,918,040.00	(€1.17)	-164.58
KWS SAAT SE & Co. KGaA	$1.28 billion	1.89	$95.60 million	€2.90	25.27

KWS SAAT SE & Co. KGaA has higher revenue and earnings than Shop Apotheke Europe. Shop Apotheke Europe is trading at a lower price-to-earnings ratio than KWS SAAT SE & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Shop Apotheke Europe and KWS SAAT SE & Co. KGaA's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shop Apotheke Europe	N/A	N/A	N/A
KWS SAAT SE & Co. KGaA	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Shop Apotheke Europe and KWS SAAT SE & Co. KGaA, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shop Apotheke Europe	1	4	7	0	2.50
KWS SAAT SE & Co. KGaA	0	4	0	0	2.00

Shop Apotheke Europe currently has a consensus target price of €199.75, indicating a potential upside of 4.09%. KWS SAAT SE & Co. KGaA has a consensus target price of €70.67, indicating a potential downside of 3.46%. Given Shop Apotheke Europe's stronger consensus rating and higher probable upside, equities analysts clearly believe Shop Apotheke Europe is more favorable than KWS SAAT SE & Co. KGaA.

Shop Apotheke Europe vs. zooplus Stock

Shop Apotheke Europe (ETR:SAE) and zooplus (ETR:ZO1) are both consumer defensive companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, risk and dividends.

Analyst Ratings

This is a summary of current ratings and recommmendations for Shop Apotheke Europe and zooplus, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shop Apotheke Europe	1	4	7	0	2.50
zooplus	1	4	2	0	2.14

Shop Apotheke Europe currently has a consensus price target of €199.75, indicating a potential upside of 4.09%. zooplus has a consensus price target of €213.14, indicating a potential downside of 15.08%. Given Shop Apotheke Europe's stronger consensus rating and higher probable upside, equities analysts clearly believe Shop Apotheke Europe is more favorable than zooplus.

Earnings and Valuation

This table compares Shop Apotheke Europe and zooplus' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shop Apotheke Europe	$968.06 million	3.56	$-20,918,040.00	(€1.17)	-164.58
zooplus	$1.81 billion	0.99	$18.87 million	€2.64	95.08

zooplus has higher revenue and earnings than Shop Apotheke Europe. Shop Apotheke Europe is trading at a lower price-to-earnings ratio than zooplus, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Shop Apotheke Europe and zooplus' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shop Apotheke Europe	N/A	N/A	N/A
zooplus	N/A	N/A	N/A

Shop Apotheke Europe vs. HORNBACH Holding AG & Co. KGaA Stock

Shop Apotheke Europe (ETR:SAE) and HORNBACH Holding AG & Co. KGaA (ETR:HBH) are both consumer defensive companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, profitability, risk and earnings.

Analyst Recommendations

This is a summary of current recommendations for Shop Apotheke Europe and HORNBACH Holding AG & Co. KGaA, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shop Apotheke Europe	1	4	7	0	2.50
HORNBACH Holding AG & Co. KGaA	0	0	2	0	3.00

Shop Apotheke Europe presently has a consensus price target of €199.75, indicating a potential upside of 4.09%. HORNBACH Holding AG & Co. KGaA has a consensus price target of €116.00, indicating a potential upside of 39.84%. Given HORNBACH Holding AG & Co. KGaA's stronger consensus rating and higher possible upside, analysts clearly believe HORNBACH Holding AG & Co. KGaA is more favorable than Shop Apotheke Europe.

Earnings & Valuation

This table compares Shop Apotheke Europe and HORNBACH Holding AG & Co. KGaA's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shop Apotheke Europe	$968.06 million	3.56	$-20,918,040.00	(€1.17)	-164.58
HORNBACH Holding AG & Co. KGaA	$5.49 billion	0.24	$195.50 million	€12.26	6.77

HORNBACH Holding AG & Co. KGaA has higher revenue and earnings than Shop Apotheke Europe. Shop Apotheke Europe is trading at a lower price-to-earnings ratio than HORNBACH Holding AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Shop Apotheke Europe and HORNBACH Holding AG & Co. KGaA's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shop Apotheke Europe	N/A	N/A	N/A
HORNBACH Holding AG & Co. KGaA	N/A	N/A	N/A

Summary

HORNBACH Holding AG & Co. KGaA beats Shop Apotheke Europe on 6 of the 8 factors compared between the two stocks.

Shop Apotheke Europe vs. Metro Stock

Shop Apotheke Europe (ETR:SAE) and Metro (ETR:B4B3) are both consumer defensive companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, profitability, risk and earnings.

Analyst Recommendations

This is a summary of current recommendations for Shop Apotheke Europe and Metro, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shop Apotheke Europe	1	4	7	0	2.50
Metro	3	8	0	0	1.73

Shop Apotheke Europe presently has a consensus price target of €199.75, indicating a potential upside of 4.09%. Metro has a consensus price target of €8.55, indicating a potential downside of 18.61%. Given Shop Apotheke Europe's stronger consensus rating and higher possible upside, equities research analysts clearly believe Shop Apotheke Europe is more favorable than Metro.

Earnings & Valuation

This table compares Shop Apotheke Europe and Metro's revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shop Apotheke Europe	$968.06 million	3.56	$-20,918,040.00	(€1.17)	-164.58
Metro	$24.42 billion	0.00	$4.90 million	€1.65	6.38

Metro has higher revenue and earnings than Shop Apotheke Europe. Shop Apotheke Europe is trading at a lower price-to-earnings ratio than Metro, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Shop Apotheke Europe and Metro's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shop Apotheke Europe	N/A	N/A	N/A
Metro	N/A	N/A	N/A

Shop Apotheke Europe vs. Anheuser-Busch InBev SA/NV Stock

Shop Apotheke Europe (ETR:SAE) and Anheuser-Busch InBev SA/NV (EBR:ABI) are both consumer defensive companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

Profitability

This table compares Shop Apotheke Europe and Anheuser-Busch InBev SA/NV's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Shop Apotheke Europe	N/A	N/A	N/A
Anheuser-Busch InBev SA/NV	N/A	N/A	N/A

Earnings & Valuation

This table compares Shop Apotheke Europe and Anheuser-Busch InBev SA/NV's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shop Apotheke Europe	$968.06 million	3.56	$-20,918,040.00	(€1.17)	-164.58
Anheuser-Busch InBev SA/NV	N/A	N/A	N/A	N/A	N/A

Anheuser-Busch InBev SA/NV has lower revenue, but higher earnings than Shop Apotheke Europe.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Shop Apotheke Europe and Anheuser-Busch InBev SA/NV, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shop Apotheke Europe	1	4	7	0	2.50
Anheuser-Busch InBev SA/NV	0	7	6	0	2.46

Shop Apotheke Europe currently has a consensus price target of €199.75, indicating a potential upside of 4.09%. Given Anheuser-Busch InBev SA/NV's higher probable upside, analysts clearly believe Anheuser-Busch InBev SA/NV is more favorable than Shop Apotheke Europe.

Summary

Shop Apotheke Europe beats Anheuser-Busch InBev SA/NV on 3 of the 4 factors compared between the two stocks.